Scientists at Karos Pharmaceuticals have reported that spirocyclic TPH1 inhibitors such as telotristat ethyl can be used to treat Pulmonary Arterial Hypertension (PAH) and Inflammatory Bowel Disease (IBD) [10]. This evidence concerns the gene TPH1 and inflammatory bowel disease.